NO156694C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.

Info

Publication number
NO156694C
NO156694C NO81812509A NO812509A NO156694C NO 156694 C NO156694 C NO 156694C NO 81812509 A NO81812509 A NO 81812509A NO 812509 A NO812509 A NO 812509A NO 156694 C NO156694 C NO 156694C
Authority
NO
Norway
Prior art keywords
propadienyl
steroids
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO81812509A
Other languages
English (en)
Other versions
NO812509L (no
NO156694B (no
Inventor
Brian W Metcalf
J O Neal Johnston
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Priority to NO81812509A priority Critical patent/NO156694C/no
Publication of NO812509L publication Critical patent/NO812509L/no
Priority to NO86861695A priority patent/NO158380C/no
Publication of NO156694B publication Critical patent/NO156694B/no
Publication of NO156694C publication Critical patent/NO156694C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/008Ketals at position 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO81812509A 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider. NO156694C (no)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO81812509A NO156694C (no) 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO86861695A NO158380C (no) 1980-06-27 1986-04-29 Nye 10-(1,2-propadienyl)steroider og antikonsepsjonsmidler inneholdende disse.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/163,453 US4289762A (en) 1980-06-27 1980-06-27 10-(1,2-Propadienyl) steroids as irreversible aromatase inhibitors
NO81812509A NO156694C (no) 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.

Publications (3)

Publication Number Publication Date
NO812509L NO812509L (no) 1983-01-24
NO156694B NO156694B (no) 1987-07-27
NO156694C true NO156694C (no) 1987-11-04

Family

ID=22590073

Family Applications (1)

Application Number Title Priority Date Filing Date
NO81812509A NO156694C (no) 1980-06-27 1981-07-22 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.

Country Status (21)

Country Link
US (1) US4289762A (no)
JP (1) JPS5738798A (no)
AT (1) AT377989B (no)
AU (1) AU539215B2 (no)
BE (1) BE889404A (no)
CA (1) CA1173432A (no)
CH (1) CH647532A5 (no)
DE (1) DE3124719C2 (no)
DK (1) DK163129C (no)
ES (1) ES8400449A1 (no)
FR (1) FR2485544A1 (no)
GB (1) GB2078750B (no)
IE (1) IE51352B1 (no)
IL (1) IL63142A0 (no)
IT (1) IT1171340B (no)
NL (1) NL8103098A (no)
NO (1) NO156694C (no)
NZ (1) NZ197495A (no)
PH (1) PH16690A (no)
SE (1) SE448878B (no)
ZA (1) ZA814219B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100566B1 (en) * 1982-07-14 1986-02-19 Akzo N.V. Novel 19-thio-androstane derivatives
US4495102A (en) * 1982-09-03 1985-01-22 G. D. Searle & Co. Aminoalkyl steroids
EP0114033B1 (de) * 1982-12-21 1988-10-12 Ciba-Geigy Ag Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen
DE3323321A1 (de) * 1983-06-24 1985-01-03 Schering AG, 1000 Berlin und 4709 Bergkamen Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels
US4634694A (en) * 1984-01-14 1987-01-06 Akzo N.V. Novel Δ4 - and Δ5 -androstene derivatives and pharmaceutical compositions containing these derivatives
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3705990A1 (de) * 1987-02-20 1988-09-01 Schering Ag 1-methyl-15(alpha)-(1-oxyalkyl)-androsta-1,4-dien- 3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3714965A1 (de) * 1987-04-30 1988-11-10 Schering Ag 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
US4910191A (en) * 1988-06-28 1990-03-20 Merrell Dow Pharmaceuticals Inc. 19-substituted progesterone derivatives useful as 19-hydroxylase inhibitors
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE4435368A1 (de) * 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
EP1708169A1 (en) 1995-02-01 2006-10-04 Seiko Epson Corporation Driving circuit and active matrix substrate and liquid crystal display device including it
PL366554A1 (en) * 2001-04-17 2005-02-07 Ares Trading S.A. Aromatase inhibition to enhance assisted reproduction
DE10141937A1 (de) * 2001-08-28 2003-03-27 Alfred Schmidt Markierung der Aromatase
EP1854465A1 (en) * 2006-05-12 2007-11-14 Alexander Tobias Teichmann Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
WO2011127232A2 (en) 2010-04-08 2011-10-13 Emory University Substituted androst-4-ene diones
EP3666276A1 (en) 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Medication against estrogen-receptor beta (erbeta) positive breast tumor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3102127A (en) * 1962-06-12 1963-08-27 Syntex Corp 19-methylene-androstane derivatives
FR1519387A (fr) * 1966-04-20 1968-03-29 Hoffmann La Roche Procédé pour la préparation de 19-alcényl-stéroïdes
DE2310963A1 (de) * 1972-04-14 1974-09-05 Schering Ag Methode zur kontrazeption durch verabfolgung von stufenkombinationspraeparaten
CH606101A5 (no) * 1975-01-30 1978-10-13 Ciba Geigy Ag

Also Published As

Publication number Publication date
IE811435L (en) 1981-12-27
AT377989B (de) 1985-05-28
DE3124719A1 (de) 1982-03-18
US4289762A (en) 1981-09-15
DK163129C (da) 1992-06-09
JPS5738798A (en) 1982-03-03
DK284481A (da) 1981-12-28
ATA285881A (de) 1984-10-15
PH16690A (en) 1984-01-06
AU539215B2 (en) 1984-09-13
ZA814219B (en) 1982-07-28
NO812509L (no) 1983-01-24
ES503451A0 (es) 1983-11-01
IT8148781A0 (it) 1981-06-26
SE448878B (sv) 1987-03-23
AU7236981A (en) 1982-01-07
DE3124719C2 (de) 1994-03-03
ES8400449A1 (es) 1983-11-01
CH647532A5 (de) 1985-01-31
GB2078750A (en) 1982-01-13
FR2485544A1 (fr) 1981-12-31
IE51352B1 (en) 1986-12-10
CA1173432A (en) 1984-08-28
GB2078750B (en) 1984-08-22
NL8103098A (nl) 1982-01-18
NO156694B (no) 1987-07-27
IL63142A0 (en) 1981-09-13
DK163129B (da) 1992-01-20
JPH0121158B2 (no) 1989-04-19
SE8103988L (sv) 1981-12-28
BE889404A (fr) 1981-12-28
NZ197495A (en) 1985-01-31
IT1171340B (it) 1987-06-10
FR2485544B1 (no) 1983-12-16

Similar Documents

Publication Publication Date Title
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
NO792787L (no) Fremgangsmaate ved fremstilling av antiinflammatorisk aktive 4,5-diaryl-2-nitroimidazoler
NO160521C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner.
NO158021C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat.
NO156752C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(1-piperidinylalkyl)-4hpyrido(1,2-a)pyrimidin-4-0n derivater
NO158540C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser.
NO166320C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
NO156693C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-propynylsteroider.
NO156694C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(1,2-propadienyl)-steroider.
NO152091C (no) Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-difenylthiofener
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO161679C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive steroider.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO157976C (no) Analogifremgangsm te ved fremstilling av terapeutisk aktive 3-fenoxy-1-azetidincarboxamider.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO164416C (no) Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner.
NO158673C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.
NO157934C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglykosider.